Use of pkc inhibitors for the manufacture of a medicament...

Details Use of pkc inhibitors for the manufacture of a medicament... Use of pkc inhibitors for the manufacture of a medicament...

A - Human Necessities

61

K

A61K 31/40 (2006.01) A61K 31/395 (2006.01) A61K 31/404 (2006.01)

Patent

CA 2263133

A method for treating HIV infection is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((2''-ethoxy)-3'''(O)-4'''- (N,N-dimethylamino)-butane)-bis-(3,3'-indolyl)]-1(H)-pyrrole-2,5-dione or its acid salt.

Procédé de traitement de certaines infections causées par le virus de l'immunodéficience humaine (HIV), particulièrement au moyen de l'inhibiteur de la protéine kinase c (PKC) à isoenzyme sélective, (S)-3,4-[N,N'-1,1'-((2"-éthoxy)-3'''(0)-4'''-(N,N-diméthylamino)-butane)-bis-(3,3'-indoly1)]-(H)-pyrrole-2,5-dione ou son sel acide.

Affiliated with

Also associated with

Rating

Use of pkc inhibitors for the manufacture of a medicament... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pkc inhibitors for the manufacture of a medicament..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pkc inhibitors for the manufacture of a medicament... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1828454